Salem Investment Counselors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Salem Investment Counselors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,000	Closed	-$40K	–	1154
2022 Q2	$40K	Hold	20,000	–	–	﹤0.01%	542
2022 Q1	$47K	Hold	20,000	–	–	﹤0.01%	521
2021 Q4	$93K	Hold	20,000	–	–	﹤0.01%	461
2021 Q3	$153K	Hold	20,000	–	–	0.01%	369
2021 Q2	$194K	Hold	20,000	–	–	0.01%	331
2021 Q1	$165K	Hold	20,000	–	–	0.01%	305
2020 Q4	$137K	Buy	+20,000	New	+$161K	0.01%	314

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Salem Investment Counselors's SRNE Position: Q3 2022 in Review

Salem Investment Counselors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2022, closing a stake of 20,000 shares — an estimated $40K sold.

Salem Investment Counselors first reported a position in SRNE in Q4 2020 and held it in 7 quarters. The position peaked at $194K in Q2 2021. 233 funds tracked by Wall St. Rank hold SRNE as of Q3 2022.

Salem Investment Counselors reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
Salem Investment Counselors sold 20,000 Sorrento Therapeutics, Inc. shares in Q3 2022, an estimated $40K.
Salem Investment Counselors first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 7 quarters.
Salem Investment Counselors's Sorrento Therapeutics, Inc. position peaked at $194K in Q2 2021.
233 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2022.

Based on Salem Investment Counselors's 13F filing for Q3 2022, filed 9 Nov 2022.